(Q34435497)

2 August 2017

1 reference

title

Biological features of primary APL blasts: their relevance to the understanding of granulopoiesis, leukemogenesis and patient management (English)

1 reference

2 August 2017

Cassinat B

1

1 reference

2 August 2017

Chomienne C

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

20

1 reference

2 August 2017

issue

49

1 reference

2 August 2017

page(s)

7154-7160

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204761

2 August 2017

exact match

0 references

cites work

All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: intracellular concentrations and biologic response relationship.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Leukocyte alkaline phosphatase a specific marker for the post-mitotic neutrophilic granulocyte: regulation in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Role of the histone deacetylase complex in acute promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Deregulated expression of promyelocytic leukemia zinc finger protein in B-cell chronic lymphocytic leukemias does not affect cyclin A expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

All-trans retinoic acid and induction of apoptosis in acute promyelocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Role of PML in cell growth and the retinoic acid pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Regulation of granulopoiesis by transcription factors and cytokine signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

Characterization of nuclear retinoic acid binding activity in sensitive leukemic cell lines: cell specific uptake of ATRA and RAR alpha protein modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

7 January 2021

The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

7 January 2021

Genomic organization and chromosomal localization of mouse proteinase 3 (Myeloblastin)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

7 January 2021

Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

7 January 2021

The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

7 January 2021

Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

7 January 2021

In vitro effect of granulocyte-colony stimulating factor and all-trans retinoic acid on the expression of inflammatory cytokines and adhesion molecules in acute promyelocytic leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

7 January 2021

Mutant AF-2 domain of PML-RARalpha in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARalpha and its down-regulation in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

7 January 2021

Retinoic acid biosynthesis and metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

7 January 2021

Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: characterization of additional microgranular variants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

7 January 2021

Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

7 January 2021

Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

7 January 2021

Acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204761

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204761

1 reference

Dimensions Publication ID

2 August 2017

1034014072

0 references

1 reference